| ABT-267, ABT 333, ABT-450 and Ritonavir |
AbbVie |
June 2017 |
|
| Bedaquiline (TMC207) |
Janssen Research & Development |
February 2019 |
|
| Cemiplimab (REGN2810) - New |
Regeneron Pharmaceuticals, Inc. |
May 2019 |
|
| Dapivirine (Microbicide Gel) |
International Partnership for Microbicides |
May 2017 |
|
| Dapivirine (Vaginal Ring) |
International Partnership For Microbicides |
July 2018 |
|
| Delamanid (OPC-67683) |
Otsuka |
April 2019 |
|
| Dolutegravir (GSK1349572) |
ViiV Healthcare |
November 2018 |
|
| Doravirine (MK-1439) - New |
Merck |
May 2019 |
|
| Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate (MK-1439A) - New |
Merck |
May 2019 |
|
| Emtricitabine/Tenofovir Disoproxil Fumarate (Truvada) |
Gilead Sciences |
December 2016 |
YES |
| Etravirine (TMC125, Intelence) |
Janssen Research & Development |
April 2018 |
|
| Glecaprevir (ABT-493) and Pibrentasvir (ABT-530) - New |
AbbVie |
December 2018 |
|
| GSK1265744 (Cabotegravir) |
ViiV Healthcare |
December 2018 |
|
| HEC Placebo Gel |
CONRAD |
September 2011 |
|
| Maraviroc (UK-427857) |
ViiV Healthcare |
October 2017 |
|
| PC-1005 |
Population Council |
April 2017 |
|
| Raltegravir (Isentress) |
Merck |
September 2017 |
YES |
| Rifapentine |
Sanofi |
August 2013 |
|
| Rilpivirine (TMC278, Edurant) - New |
Janssen Research & Development |
July 2019 |
|
| Sofosbuvir/Velapatasvir (Epclusa) |
Gilead |
July 2016 |
|
